Introduction
============

Adult cardiomyocytes are highly polarized, with a rod shape and the majority of their cell junction proteins localized to the intercalated discs joining the cells end to end to facilitate electrical conduction and contraction of the heart^[@b1]^; however, during embryonic development, cardiomyocytes are initially formed in spherical shapes. They begin to elongate at E13.5 and gradually assume a rod shape during fetal and postnatal development. The spatial differences or asymmetries in shape, orientation and structure of cells define cell polarity, which is controlled by planar cell polarity (PCP) signaling, also known as the noncanonical Wnt pathway.^[@b2]^ Initially identified in *Drosophila*, the PCP pathway is well conserved in mammalian species.^[@b1],[@b3]^ The ligands of this pathway include Wnt5a and Wnt11. The transmembrane receptors involved are Frizzled and Vangl2/Scrib. Through recruitment of Dishevelled, the PCP signals are transduced to the small GTPases RhoA and Rac, which in turn regulate actin polymerization and cell polarity.^[@b1]--[@b2]^ The important role of PCP signaling in regulating cardiomyocyte polarity and embryonic heart development has recently emerged. Genetic knockout or mutation of PCP components such as *Wnt11*,*Vangl2*,*Scrib*, and *Dishevelled2* in mice all show congenital heart defects (CHDs).^[@b4]--[@b6]^ In addition, *Wnt11*^*−/−*^ and *Vangl2* mutant mice show thin myocardium and defects in cardiomyocyte elongation, organization, and migration^[@b4]--[@b5]^; however, the role of Rac in cardiomyocyte polarity and embryonic heart development is unknown.

Rac GTPases are small (20 to 30 kDa), monomeric, signaling GTP‐binding proteins that are a subfamily of the Rho family of GTPases with 4 members: Rac1, Rac2, Rac3, and RhoG.^[@b7]^ Rac1 is a key molecule in the PCP pathway to promote cell polarity of the eyes and wings in *Drosophila*.^[@b8]--[@b9]^ Rac1 is also an important regulator of cell migration and survival. Whole‐body *Rac1*^*−/−*^ mice die before E9.5, with defects in germ layer formation due to reduced cell adhesion and motility and increased apoptosis within the mesoderm.^[@b10]^ Moreover, *Rac1*^*−/−*^ embryos fail to specify an anterior--posterior axis because cells in the anterior visceral endoderm do not migrate,^[@b11]^ suggesting an important role of Rac1 in cell polarity during embryogenesis.

The heart develops from 3 distinct populations of cells: the first heart field, the second heart field (SHF), and the cardiac neural crest. Initially, the primary heart tube is formed mainly from the first heart field progenitors. SHF cells are then added to the heart tube to form the right ventricle (RV) and the outflow tract, with contributions from the cardiac neural crest cells.^[@b12]--[@b13]^ In addition, SHF progenitors are critical to the formation of the cardiac septum. Abnormalities in SHF development result in CHDs in mice including septal defects, which are some of the most common types of CHDs in humans.^[@b14]--[@b15]^ To specifically study the role of Rac1 in cardiomyocyte polarity and RV and cardiac septal development, we generated a novel mouse model with an SHF‐specific (or anterior heart field‐specific) deficiency of *Rac1* (*Rac1*^*SHF*^) using the *Mef2c‐Cre* mouse, which directs Cre activity in the SHF.^[@b16]^ Our results show that Rac1 signaling in the SHF is critical to cardiomyocyte polarity, cardiac septation, and RV development.

Methods
=======

Mice
----

*Rac1*^*f/f*^ mice (stock no. 5550)^[@b17]^ and membrane‐targeted Tomato (mT)/membrane‐targeted green fluorescent protein (mG) mice (stock no. 7676)^[@b18]^ were obtained from Jackson Laboratory (Bar Harbor, Maine). The *mT/mG* mouse is a global double‐fluorescent Cre reporter mouse that expresses mT before Cre‐excision and mG after excision of mT.^[@b18]^ The *Mef2c‐Cre* embryos^[@b16]^ were obtained from Mutant Mouse Regional Resource Centers (Chapel Hill, North Carolina) and rederived. A breeding program was carried out to generate *Mef2c‐Cre:Rac1*^*f/f*^ (*Rac1*^*SHF*^), *Mef2c‐Cre:mT/mG*, and *Rac1*^*SHF*^*:mT/mG* transgenic mice. Genotyping was performed by polymerase chain reaction (PCR) using genomic DNA from tail biopsies. Primer sequences are shown in [Table 1](#tbl01){ref-type="table"}. All mouse experiments and procedures were carried out in accordance with the guidelines of the Canadian Council of Animal Care and approved by the animal use subcommittee at the University of Western Ontario.

###### 

The Genotyping Polymerase Chain Reaction Primer Sequences

  ------------------------------------------------------------------
  Gene             Forward                 Reverse
  ---------------- ----------------------- -------------------------
  *Mef2c‐Cre*      tgccacgaccaagtgacagc    ccaggttacggatatagttcatg

  *Rac1* ^*f/f*^   tccaatctgtgctgcccatc    gatgcttctaggggtgagcc

  *mT/mG*          ctctgctgcctcctggcttct   cgaggcggatcacaagcaata\
                                           Mutant reverse:\
                                           tcaatgggcgggggtcgtt
  ------------------------------------------------------------------

Histological Analysis
---------------------

Neonatal and embryonic samples were fixed overnight in 4% paraformaldehyde at 4°C, dehydrated, and paraffin embedded. Embryos were serially sectioned at 5 μm from the top of the aortic arch to the apex with a Leica RM2255 microtome. Sections were mounted onto positively charged albumin/glycerin‐coated microslides in a set of 5, with 25‐μm intervals between each section. Slides were stained with hematoxylin and eosin for histological analysis. Images were captured using a light microscope (Observer D1, Zeiss).

Immunohistochemistry
--------------------

Immunohistochemical staining was performed on heart sections (5 μm). Antigen retrieval was carried out in sodium citrate buffer (pH 6.0) at 92°C using a BP‐111 laboratory microwave (Microwave Research and Applications). Immunostaining was performed with primary antibodies for Rac1 (Santa Cruz Biotechnology), phosphohistone‐H3 (phospho S10) (Abcam), cleaved caspase‐3 (Cell Signaling Technology), active (nonphosphorylated) β‐catenin (Cell Signaling Technology), and green fluorescent protein (Abcam). All slides were imaged with a Zeiss Observer D1 microscope using AxioVision Rel 4.7 software. For phalloidin and wheat germ agglutinin staining, P0 heart samples were fixed in 4% paraformaldehyde, cryoprotected in 30% sucrose, embedded in FSC22 frozen section media (Leica), and sectioned with a Leica cryostat at 10‐μm thick onto glass slides. Slides were incubated with Alexa Fluor 488 phalloidin (Life Technologies), Alexa Fluor 647 wheat germ agglutinin (Invitrogen), and Hoechst 33342 (Invitrogen). Confocal images were obtained with a Zeiss LSM 510 Duo microscope using ZEN 2012 software (Zeiss).

Western Blot Analysis
---------------------

Rac1 protein expression from P0 RV was measured by Western blot analysis. Briefly, 40 μg of protein from isolated RV tissue was separated by 12% SDS‐PAGE gel and transferred to nitrocellulose membranes. Blots were probed with antibodies against Rac1 (1:500; Santa Cruz Biotechnology) and GAPDH (1:3000; Santa Cruz Biotechnology). Blots were then washed and probed with horseradish peroxidase--conjugated secondary antibodies (1:2500; Bio‐Rad) and detected using an enhanced chemiluminescence detection method. Signal quantification was performed by densitometry.

RV Explant Culture
------------------

Embryos were harvested at E12.5, and embryonic hearts were dissected to separate RV tissue from the whole heart. RV tissues were cultured on 1% collagen‐coated tissue culture plastic multiwell plates, as described previously^[@b19]^ with the following adaptations. Explants were incubated for 6 days at 37°C with 5% CO~2~ in DMEM containing 10% fetal bovine serum and 1% penicillin/streptomycin. Media was refreshed every 2 days.

Quantitative Reverse Transcription PCR
--------------------------------------

Total RNA was isolated from E13.5 RV using the RNeasy Mini Kit (Qiagen). Reverse transcription reaction was performed using M‐MLV reverse transcriptase (Invitrogen), and EvaGreen qPCR Mastermix (Applied Biological Materials) was used for real‐time thermal cycling. Samples were amplified for 35 cycles using the Eppendorf Mastercycler Realplex Real‐Time PCR machine. In addition, 28S ribosomal RNA was used as an internal control. Primer sequences are shown in [Table 2](#tbl02){ref-type="table"}. The mRNA levels in relation to 28S ribosomal RNA were determined using a comparative C~T~ method.^[@b20]^

###### 

The Real‐Time Reverse Transcription Polymerase Chain Reaction Primer Sequences

  Gene       Forward                   Reverse
  ---------- ------------------------- --------------------------
  *Arp2*     ggcttttctctccctcacct      gcttctgctcctgctcaata
  *Arp3*     cggcgtcctctctacaagaa      cagcattgaccctccaaacc
  *Abi1*     ttgactccacagatccctctcac   ttcatagtccacaggaggaggtg
  *WAVE2*    gcaaggaagagtgggagaagatg   cagagaatgaaggggaaggtgag
  *Nkx2.5*   tcaatgcctatggctacaacg     gacgccaaagttcacgaagttgct
  *Gata4*    cactatgggcacagcagctc      gcctgcgatgtctgagtgac
  *Tbx5*     acacaggatgtctcggatgc      gttaggtgggggcagaaggt
  *Rac1*     aacctgcctgctcatcagtt      ttgtccagctgtgtcccata
  *Tbx20*    cacctatggggaagaggatgttc   gtcgctatggatgctgtactggt
  *Hand2*    gctacatcgcctacctcatggat   tcttgtcgttgctgctcactgt
  *28S*      ttgaaaatccgggggagag       acattgttccaacatgccag

Scratch Assay
-------------

Wild‐type neonatal cardiomyocytes were prepared and cultured, as described previously.^[@b21]^ Cardiomyocytes were infected with adenoviruses expressing a dominant‐negative form of Rac1 (Ad‐Rac1N17; Vector Biolabs) or β‐galactosidase (Ad‐β‐gal; Vector Biolabs) as a control at a multiplicity of infection of 10 plaque forming units per cell. The scratch was performed 6 hours after adenoviral infection. Cells were fixed and immunostained with primary antibodies for Rac1 (Santa Cruz Biotechnologies) and α‐actinin (Sigma‐Aldrich) 24 hours after scratch.

Statistical Analysis
--------------------

Data are mean±SEM. Unpaired Student *t* test was used when data passed a normality test. Nonparametric Mann--Whitney test was used when samples size was 3 to 4 per group. Differences were considered significant at *P*≤0.05.

Results
=======

Generation of a Transgenic Mouse With *Rac1* Knockdown in the SHF
-----------------------------------------------------------------

To elucidate the role of *Rac1* in the SHF, the *Mef2c*‐*Cre* mouse was crossed with the *Rac1*^*f/f*^ mouse to generate *Mef2c‐Cre:Rac1*^*f/f*^ (*Rac1*^*SHF*^) offspring. *Rac1*^*SHF*^ mice have the *Rac1* gene specifically knocked down in SHF progenitors and their derivatives. Embryonic samples were collected, and loss of the *Rac1* transcript was confirmed in *Rac1*^*SHF*^ hearts by quantitative reverse‐transcription PCR. *Rac1* mRNA expression was reduced by 51% in the RV myocardium of E13.5 *Rac1*^*SHF*^ compared with littermate *Rac1*^*f/f*^ controls ([Figure 1](#fig01){ref-type="fig"}A). Immunostaining for Rac1 protein was also performed to further confirm the loss of myocardial *Rac1* expression in SHF derivatives. In P0 *Rac1*^*SHF*^ hearts, robust staining for Rac1 was observed in the left ventricle (LV). In the same P0 *Rac1*^*SHF*^ heart section, the Rac1 signal intensity was markedly decreased in the RV when compared with the LV ([Figure 1](#fig01){ref-type="fig"}B). Ratio of Rac1 to GAPDH protein was reduced by 40% in P0 *Rac1*^*SHF*^ RV compared with littermate *Rac1*^*f/f*^ controls, as determined by Western blot analysis ([Figure 1](#fig01){ref-type="fig"}C). These data show that the *Mef2c‐Cre--*mediated recombination downregulates *Rac1* expression in SHF derivatives of the embryonic heart.

![A, *Rac1*mRNA levels were significantly decreased in *Rac1*^*SHF*^ RV compared with *Rac1*^*f/f*^ controls at E13.5, as measured by quantitative reverse transcription polymerase chain reaction. \*\**P*\<0.01 by unpaired Student *t* test. B, Immunostaining shows that Rac1 protein levels were reduced in P0 *Rac1*^*SHF*^ RV compared with the left ventricle myocardium. C, Western blot analysis of P0 RV showed a significant decrease in Rac1 protein in *Rac1*^*SHF*^ compared with *Rac1*^*f/f*^ controls. \**P*\<0.05 by Mann--Whitney test. RV indicates right ventricle; SHF, second heart field.](jah3-3-e001271-g1){#fig01}

Deficiency of *Rac1* in the SHF Results in CHDs
-----------------------------------------------

The most prominent defect on initial analysis of P0 *Rac1*^*SHF*^ hearts was a gross morphological abnormality in the overall shape of the heart. Instead of a distinct apex, all P0 *Rac1*^*SHF*^ hearts (28 of 28) had a deep interventricular groove and bifurcation of the 2 ventricles, resulting in a bifid cardiac apex, a rare CHD in humans ([Table 3](#tbl03){ref-type="table"}; [Figure 2](#fig02){ref-type="fig"}A and [2](#fig02){ref-type="fig"}B). Atrial septal defects were observed in 82% (23 of 28) of *Rac1*^*SHF*^ hearts but not in littermate control *Rac1*^*f/f*^ P0 hearts (0 of 19) ([Table 3](#tbl03){ref-type="table"}; [Figure 2](#fig02){ref-type="fig"}C and [2](#fig02){ref-type="fig"}D). Ventricular septal defects were seen in 100% (28 of 28) of P0 *Rac1*^*SHF*^ hearts ([Table 3](#tbl03){ref-type="table"}; [Figure 2](#fig02){ref-type="fig"}C and [2](#fig02){ref-type="fig"}D). In addition, the RV myocardium had poor trabeculation and the compact myocardium was significantly thinner in *Rac1*^*SHF*^ hearts compared with littermate controls ([Figure 2](#fig02){ref-type="fig"}E through [2](#fig02){ref-type="fig"}G; [Table 3](#tbl03){ref-type="table"}). These findings suggest a critical role for SHF *Rac1* signaling in cardiac septation and RV development.

###### 

Incidence of Congenital Heart Defects in P0 *Rac1*^*SHF*^ Hearts

                 Rac1^f/f^ (n=19)   Mef2c‐Cre:Rac1^f/+^ (n=10)   Rac1^SHF^ (n=28)[\*](#tf3-1){ref-type="table-fn"}              
  -------------- ------------------ ---------------------------- --------------------------------------------------- ----- ---- -----
  Normal         19                 100                          10                                                  100   0    0
  ASD            0                  0                            0                                                   0     23   82
  VSD            0                  0                            0                                                   0     28   100
  Bifid apex     0                  0                            0                                                   0     28   100
  Defective RV   0                  0                            0                                                   0     28   100

ASD indicates atrial septal defect; RV, right ventricle; VSD, ventricular septal defect.

21 alive and 7 collected dead at P0. Because penetrance of congenital heart defects is 100% in Rac1^SHF^ hearts, statistical analysis is not necessary.

![*Mef2c‐Cre--*induced *Rac1* deletion in SHF results in congenital heart defects. A and B, Bifurcation between RV and LV (arrow) in P0 *Rac1*^*SHF*^ hearts. C and D, Atrial septal defect (arrow head) and ventricular septal defect (arrow) were found in P0 *Rac1*^*SHF*^ hearts. E through G, P0 *Rac1*^*SHF*^ RV compact myocardium (double arrows) was significantly thinner. \*\*\**P*\<0.001 by unpaired Student *t* test. Scale bars: 100 μm (C and D), 50 μm (E and F). LA indicates left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle; SHF, second heart field.](jah3-3-e001271-g2){#fig02}

*Rac1*^*SHF*^ Hearts Exhibit Defective Cardiomyocyte Polarity
-------------------------------------------------------------

Cardiomyocyte organization and alignment were severely disrupted in P0 *Rac1*^*SHF*^ hearts. Cell membrane staining with wheat germ agglutinin revealed rounded, spherically shaped cardiomyocytes in *Rac1*^*SHF*^ RV ([Figure 3](#fig03){ref-type="fig"}B) compared with *Rac1*^*f/f*^ RV, which had elongated cardiomyocytes ([Figure 3](#fig03){ref-type="fig"}A). Actin cytoskeleton organization was also severely disrupted in *Rac1*^*SHF*^ RV, as shown by phalloidin staining to mark F‐actin filaments ([Figure 3](#fig03){ref-type="fig"}D). *Rac1*^*SHF*^ RV had an absence of long F‐actin filaments, whereas *Rac1*^*f/f*^ RV myocardium exhibited long, parallel running F‐actin fibers ([Figure 3](#fig03){ref-type="fig"}C). In addition, active (nonphosphorylated) β‐catenin staining between cell junctions was also reduced in E13.5 *Rac1*^*SHF*^ RV compared with *Rac1*^*f/f*^ RV ([Figure 3](#fig03){ref-type="fig"}E and [3](#fig03){ref-type="fig"}F). These data strongly suggest disruption of cardiomyocyte polarity in *Rac1*^*SHF*^ hearts.

![*Rac1*^*SHF*^ hearts exhibit defective polarity. A and B, WGA staining to mark cell membranes of P0 *Rac1*^*SHF*^ RV shows rounded cardiomyocytes compared with the elongated cells of littermate controls. C and D, Phalloidin staining to mark F‐actin shows disorganization in cellular structure and a deficiency in long actin filaments in the *Rac1*^*SHF*^ RV. E and F, Active (nonphosphorylated) β‐catenin staining is reduced at cell--cell junctions in E13.5 *Rac1*^*SHF*^ RV. White arrows indicate cell adhesion. Scale bars: 20 μm (A through D), 10 μm (E and F). RV indicates right ventricle; SHF, second heart field; WGA, wheat germ agglutinin.](jah3-3-e001271-g3){#fig03}

Expression of Scrib Protein Is Lost in *Rac1*^*SHF*^ Hearts
-----------------------------------------------------------

Scrib, the mouse homolog of the *Drosophila* protein Scribble, is a component of the PCP pathway. Immunostaining shows Scrib protein was expressed mainly in the lower part of RV and the cardiac apex in *Rac1*^*f/f*^ hearts ([Figure 4](#fig04){ref-type="fig"}A, [4](#fig04){ref-type="fig"}B, [4](#fig04){ref-type="fig"}E, and [4](#fig04){ref-type="fig"}F), and the number of Scrib‐positive cells was about 10 times higher in E15.5 than E12.5 *Rac1*^*f/f*^ hearts ([Figure 4](#fig04){ref-type="fig"}I and [4](#fig04){ref-type="fig"}J). Notably, Scrib expression was almost absent in both E12.5 and E15.5 *Rac1*^*SHF*^ hearts ([Figure 4](#fig04){ref-type="fig"}C, and [4](#fig04){ref-type="fig"}D, [4](#fig04){ref-type="fig"}G, and [4](#fig04){ref-type="fig"}H), and the number of Scrib‐positive cells was significantly decreased in *Rac1*^*SHF*^ hearts compared with littermate controls ([Figure 4](#fig04){ref-type="fig"}I and [4](#fig04){ref-type="fig"}J). The loss of Scrib expression suggests disruption of the PCP pathway and further supports failure to establish cardiomyocyte polarity in *Rac1*^*SHF*^ hearts.

![Decreased Scrib protein expression in *Rac1*^*SHF*^ hearts. A through D, Scrib immunostaining was performed on E12.5 paraffin sections. Arrows indicate Scrib protein expression. B and D are magnifications of boxes in A and C, respectively. E through H, Scrib immunostaining was performed on E15.5 paraffin sections. Arrows indicate Scrib protein expression. F and H are magnifications of boxes in E and G, respectively. I, J, Number of Scrib‐positive cells was significantly decreased in E12.5 and E15.5 *Rac1*^*SHF*^ hearts. n=3 hearts per group, \**P*=0.05 by Mann--Whitney test. Scale bars: 100 μm (A, C, E, G), 20 μm (B, D, F, H). LA indicates left atrium; LV, left ventricle; RV, right ventricle; SHF, second heart field.](jah3-3-e001271-g4){#fig04}

*Rac1* Is Required for Lamellipodia Formation and Cardiomyocyte Migration
-------------------------------------------------------------------------

Cell migration is a fundamental process of gastrulation, morphogenesis, and formation of organs and tissues during development.^[@b22]^ To determine whether Rac1 plays a migratory role in SHF derived‐cells, RV from E12.5 *Rac1*^*SHF*^*:*mT/mG and control *Mef2c‐Cre:Rac1*^*f/+*^*:*mT/mG hearts were isolated and explants cultured on collagen gels for 6 days. The mT/mG global double‐fluorescent Cre reporter mouse expresses mT before Cre‐mediated excision and mG after excision of mT.^[@b18]^ Thus all SHF‐derived cells in *Rac1*^*SHF*^*:*mT/mG and *Mef2c‐Cre:Rac1*^*f/+*^*:*mT/mG are positive for green fluorescent protein. It was observed that *Mef2c‐Cre:Rac1*^*f/+*^*:*mT/mG control explants had both non‐SHF‐derived (mT‐labeled) and SHF‐derived (mG‐labeled) cells migrating from the RV explant by day 6 ([Figure 5](#fig05){ref-type="fig"}A through [5](#fig05){ref-type="fig"}C). In contrast, *Rac1*^*SHF*^*:*mT/mG explants had only non‐SHF‐derived (mT‐labeled) cells migrating from the RV explant and very few to no SHF‐derived (mG‐labeled) cell migration ([Figure 5](#fig05){ref-type="fig"}D through [5](#fig05){ref-type="fig"}F). The migration defects observed in the *Rac1*^*SHF*^*:*mT/mG RV explants indicate that *Rac1* regulates migration of SHF‐derived progenitor cells, likely through actin organization controlled by the Wiskott‐Aldrich syndrome protein family verprolin‐homologous protein (WAVE) and actin‐related protein‐2/3 (Arp2/3) pathway downstream of Rac1.^[@b23]^ A significant decrease was found in *Abi1*,*WAVE2*,*Arp2*, and *Arp3* expression---components of the WAVE and Arp2/3 complex---in E13.5 *Rac1*^*SHF*^ RV compared with littermate controls ([Table 4](#tbl04){ref-type="table"}).

###### 

Real‐Time Polymerase Chain Reaction Analysis of Gene mRNA Levels in E13.5 *Rac1*^*SHF*^ Right Ventricle

  Gene        *Rac1* ^*f/f*^         *Rac1* ^*SHF*^         *P* Values
  ----------- ---------------------- ---------------------- ------------
  *Nkx2.5*    0.0583±0.00423 (n=6)   0.0462±0.00467 (n=6)   0.0320
  *Gata4*     0.0410±0.00206 (n=6)   0.0299±0.00405 (n=6)   0.0338
  *Tbx5*      0.0124±0.00043 (n=8)   0.0090±0.00135 (n=8)   0.0320
  *Hand2*     0.0315±0.00281 (n=6)   0.0211±0.00116 (n=6)   0.0065
  *Tbx20*     0.0428±0.0038 (n=6)    0.0331±0.00423 (n=8)   0.1256
  *Abi1*      0.0268±0.00215 (n=8)   0.0177±0.00341 (n=8)   0.0404
  *WAVE2*     0.1174±0.00902 (n=8)   0.0756±0.0140 (n=8)    0.0247
  *Arp2*      0.0246±0.00239 (n=8)   0.0167±0.00109 (n=8)   0.0098
  *Arp3*      0.1306±0.00639 (n=8)   0.0901±0.0109 (n=8)    0.0063
  β*‐actin*   0.2977±0.0395 (n=6)    0.2220±0.0298 (n=6)    0.1534

Data are ratios to 28S and are presented as mean±SEM. Significance in gene expression difference between *Rac1*^*SHF*^ and *Rac1*^*f/f*^ littermates analyzed by unpaired Student *t* test. *P*\<0.05 was considered statistically significant. No significant differences were found in *Tbx20* and β*‐actin* mRNA expression.

![Rac1 deficiency results in defective cell migration and lamellipodia formation. A through C, E12.5 RV explant cultures of *Mef2c‐Cre;*mT/mG*;Rac1*^*f/+*^ hearts have both SHF‐derived (mG) and non‐SHF‐derived (mT) migrating cells. E and F, E12.5 RV explant cultures of *Rac1*^*SHF*^*;*mT/mG hearts have only non‐SHF‐derived (mT) migrating cells without any SHF‐derived migrating cells (mG). G and H, Scratch assays of adenoviral infected neonatal cardiomyocytes show cellular projections and lamellipodia extensions (arrows) beyond the scratch edge in Ad‐β‐gal treated cells and none in Ad‐Rac1N17 treated cells 24 hours post‐scratch. Dotted white line indicates scratch edge. Shown are representative images from 3 independent experiments. Ad‐Rac1N17 indicates a dominant‐negative form of Rac1; Ad‐β‐gal, β‐galactosidase; mG, membrane‐targeted green fluorescent protein; mT, membrane‐targeted Tomato; RV, right ventricle SHF, second heart field.](jah3-3-e001271-g5){#fig05}

To further assess cell migration, scratch assays were performed on neonatal cardiomyocytes infected with adenoviral constructs of β‐galactosidase (Ad‐β‐gal) or dominant negative Rac1 (Ad‐Rac1N17). It was observed that 24 hours after scratch, Ad‐β‐gal‐treated cardiomyocytes were aligned perpendicular to the scratch edge and had projections along the scratch edge, indicative of actin organization and lamellipodia extension ([Figure 5](#fig05){ref-type="fig"}G). In contrast, no projections and lamellipodia formation were observed in Ad‐Rac1N17 cardiomyocytes, and the cells were disorganized and arranged in a random orientation along the scratch edge ([Figure 5](#fig05){ref-type="fig"}H). These findings implicate Rac1 in the regulation of cell migration and lamellipodia extension in cardiomyocytes.

*Rac1*^*SHF*^ Cardiomyocytes Are Shortened and Rounded
------------------------------------------------------

Neonatal cardiomyocyte cultures from *Rac1*^*SHF*^ RV tissues showed that these cells had disrupted actin organization, as indicated by phalloidin staining and the absence of distinct cell projections compared with *Rac1*^*f/f*^ cardiomyocytes. Interestingly, patterning of α‐actinin also seemed to be disrupted in *Rac1*^*SHF*^ cardiomyocytes ([Figure 6](#fig06){ref-type="fig"}A and [6](#fig06){ref-type="fig"}B). Measurement of cardiomyocyte long‐axis length revealed significantly shorter *Rac1*^*SHF*^ cardiomyocytes compared with littermate control cardiomyocytes ([Figure 6](#fig06){ref-type="fig"}E). In addition, neonatal *Rac1*^*SHF*^ cardiomyocytes were rounded compared with control *Rac1*^*f/f*^ cardiomyocytes, which had an elongated morphology ([Figure 6](#fig06){ref-type="fig"}C and [6](#fig06){ref-type="fig"}D). No rounded cardiomyocytes were found in *Rac1*^*f/f*^ cultures, whereas \>40% of *Rac1*^*SHF*^ cardiomyocytes exhibited a rounded morphology ([Figure 6](#fig06){ref-type="fig"}F). These data strongly support the role of Rac1 in regulating elongation and polarization of cardiomyocytes.

![Cells are rounded and cell length is reduced in cultured neonatal *Rac1*^*SHF*^ cardiomyocytes. A and B, Phalloidin and α‐actinin staining of neonatal cardiomyocytes show defective cellular organization and projection formation in *Rac1*^*SHF*^ cells. C and D, *Rac1*^*SHF*^ cardiomyocytes are a spherical shape compared with *Rac1*^*f/f*^ controls. E and F, Long‐axis measurements of *Rac1*^*SHF*^ cardiomyocytes showed that these cells are significantly shorter and more spherical compared with *Rac1*^*f/f*^ controls. n=3 independent cultures per group, \**P*=0.05 by Mann--Whitney test (E). Because penetrance of round cardiomyocyte is 0% in *Rac1*^*f/f*^ cultures, statistical analysis is not necessary (F). Scale bars: 10 μm (A and B), 20 μm (C and D). SHF indicates second heart field.](jah3-3-e001271-g6){#fig06}

Contribution of SHF Progenitors to *Rac1*^*SHF*^ Hearts Is Decreased
--------------------------------------------------------------------

Histological analysis showed that a deep fissure between the RV and LV was observed in E11.5 *Rac1*^*SHF*^ hearts, whereas this was not evident and the early muscular interventricular septum was beginning to form in littermate control hearts ([Figure 7](#fig07){ref-type="fig"}A and [7](#fig07){ref-type="fig"}B). At E12.5, bifurcation of the RV and LV in *Rac1*^*SHF*^ hearts continued to be present ([Figure 7](#fig07){ref-type="fig"}C and [7](#fig07){ref-type="fig"}D), and by E15.5, a distinct apex was formed in control hearts, whereas *Rac1*^*SHF*^ hearts continued to have a deep cleft separating the ventricles ([Figure 7](#fig07){ref-type="fig"}E and [7](#fig07){ref-type="fig"}F).

![Deficient SHF progenitor contribution to *Rac1*^*SHF*^ hearts. A through F, hematoxylin and eosin staining of E11.5, E12.5, and E15.5 heart sections shows defective interventricular septum formation (arrow) in *Rac1*^*SHF*^ hearts, leading to a bifid cardiac apex. G through L, Fate mapping with *mT/mG* reporter shows a decreased SHF progenitor contribution to the interventricular septum (arrow) in *Rac1*^*SHF*^ hearts. Paraffin sections were immunostained with anti‐GFP. Scale bars: 100 μm (A through J), 200 μm (K and L). Ao indicates aorta; GFP, green fluorescent protein; LA indicates left atrium; LV, left ventricle; mG, membrane‐targeted GFP; mT, membrane‐targeted Tomato; RA, right atrium; RV, right ventricle; SHF, second heart field.](jah3-3-e001271-g7){#fig07}

Fate mapping with the *mT/mG* global double‐fluorescent Cre reporter mouse^[@b18]^ was performed to follow the developmental progression of the SHF progenitors. A deficiency in the SHF lineage contributing to the developing E11.5 *Rac1*^*SHF*^*:mTmG* hearts was evident, especially in the early forming muscular interventricular septum between the RV and LV ([Figure 7](#fig07){ref-type="fig"}G and [7](#fig07){ref-type="fig"}H). At E12.5 and E15.5, the interventricular septum in *Rac1*^*SHF*^*:mT/mG* hearts had a major deficiency of SHF‐derived cells, leading to formation of a bifid apex ([Figure 7](#fig07){ref-type="fig"}I and [7](#fig07){ref-type="fig"}L). These findings suggest a critical role for SHF *Rac1* signaling in muscular interventricular septum formation.

*Rac1* Promotes Cell Survival in SHF‐Derived Myocardium
-------------------------------------------------------

Aberrant apoptosis or decreased proliferation in the SHF may contribute to CHDs. To determine whether an abnormality in proliferation was a factor in *Rac1*^*SHF*^ hearts, phosphohistone‐H3 protein staining was performed on E11.5 heart sections ([Figure 8](#fig08){ref-type="fig"}A through [8](#fig08){ref-type="fig"}F). No differences in proliferation were observed between *Rac1*^*SHF*^ and *Rac1*^*f/f*^ control hearts ([Figure 8](#fig08){ref-type="fig"}G). Next, we stained for cleaved caspase‐3 (the active form of caspase‐3) on E11.5 heart sections to detect cell apoptosis ([Figure 9](#fig09){ref-type="fig"}A through [9](#fig09){ref-type="fig"}D). Cleaved caspase‐3 staining was quantified as a percentage of the total number of cells. E11.5 *Rac1*^*SHF*^ hearts had significantly higher levels of apoptosis in the RV compared with littermate controls (*P*\<0.05) ([Figure 9](#fig09){ref-type="fig"}E). Similarly, increased apoptosis was observed in the interventricular septum of E11.5 *Rac1*^*SHF*^ hearts (*P*\<0.05) ([Figure 9](#fig09){ref-type="fig"}B, [9](#fig09){ref-type="fig"}D, and [9](#fig09){ref-type="fig"}E). No significant difference in apoptosis was observed in the LV between E11.5 *Rac1*^*SHF*^ and control hearts (*P*=0.27) ([Figure 9](#fig09){ref-type="fig"}E). Together, these data define a requirement for Rac1 in cell survival but not proliferation in the development of SHF‐derived cardiac structures.

![pHH3 protein staining to assess cell proliferation in E11.5 *Rac1*^*SHF*^ hearts. A through F, Representative pHH3 staining in transverse heart sections. Arrows indicate positive signals. Scale bars: 20 μm. G, No significant differences in cell proliferation were found between E11.5 *Rac1*^*SHF*^ and *Rac1*^*f/f*^ hearts. n=3 hearts per group. LV indicates left ventricle; pHH3, phosphohistone‐H3; RV, right ventricle; SHF, second heart field.](jah3-3-e001271-g8){#fig08}

![Increased apoptosis in *Rac1*^*SHF*^ RV and interventricular septum. A through D, E11.5 heart sections were immunostained with cleaved caspase‐3 antibody to mark apoptotic cells. Arrows indicate positive signals. B and D are magnifications of the boxes in A and C, respectively. E, Quantification of apoptosis in RV, LV, and the cardiac septum. \**P*\<0.05 vs corresponding Rac1^f/f^ by Mann--Whitney test. Scale bars: 100 μm (A and C), 10 μm (B and D). F, The proposed pathway of Rac1 signaling in SHF derivatives during embryonic heart development. Rac1 regulates actin organization to promote cardiomyocyte polarity and cell migration. In addition, Rac1 promotes cell survival and the expression of cardiac developmental genes. These effects of Rac1 contribute to normal RV and septal development of the heart. LV indicates left ventricle; RV, right ventricle; SHF, second heart field.](jah3-3-e001271-g9){#fig09}

Downregulation of Transcription Factors in *Rac1*^*SHF*^ RV Myocardium
----------------------------------------------------------------------

Heart development is regulated by a complex network of transcription factors that interact synergistically and in a dose‐dependent manner to activate target genes.^[@b24]^ To address the genetic pathways regulated by Rac1 signaling in the SHF, we analyzed known transcription factors important for heart development. Expression levels of *Gata4*,*Nkx2.5*, and *Tbx5* mRNA were significantly decreased in the RV of E13.5 *Rac1*^*SHF*^ compared with *Rac1*^*f/f*^ hearts ([Table 4](#tbl04){ref-type="table"}). *Hand2* and *Tbx20* are 2 transcription factors shown to be expressed predominantly in the RV and to regulate RV development.^[@b25]--[@b26]^ *Hand2* expression was significantly decreased in the RV of E13.5 *Rac1*^*SHF*^ compared with *Rac1*^*f/f*^ hearts ([Table 4](#tbl04){ref-type="table"}); however, no significant differences were found in *Tbx20* expression between *Rac1*^*f/f*^ and *Rac1*^*SHF*^ RV ([Table 4](#tbl04){ref-type="table"}). Taken together, these findings indicate that transcriptional regulation of RV development was severely disrupted in the *Rac1*^*SHF*^ hearts.

Discussion
==========

The present study was carried out to examine the role of *Rac1* in SHF progenitors. Using the SHF‐specific *Mef2c‐Cre* mouse line to delete *Rac1* in SHF progenitors and derivatives, we demonstrated that a Rac1 deficiency in the SHF leads to 100% penetrance of CHDs including septal defects, thin RV myocardium, and defective trabeculation and, most notably, a bifid cardiac apex. Our data showed, for the first time, that Rac1 signaling is critical to cardiomyocyte polarity and embryonic heart development, with contributions to cell migration and survival and cardiac gene expression ([Figure 9](#fig09){ref-type="fig"}F).

Rac1 has been shown to be a downstream effector of the PCP pathway by modulating the cytoskeleton and regulating actin dynamics in *Drosophila* and *Xenopus*^[@b9],[@b27]^; however, the role of Rac1 in mammalian cardiomyocyte polarity and heart development is not known. Studies have shown that disruption of the PCP pathway in mice by deletion of *Scrib* resulted in cellular disorganization, defective trabeculation, thin myocardium, and chamber septation defects,^[@b6]^ which are strikingly similar to the defects observed in this study and strongly support a disruption of PCP signaling in *Rac1*^*SHF*^ hearts. Interestingly, we observed that Scrib protein expression pattern is most abundant in the RV and interventricular septum junction during embryonic heart development. Notably, Scrib protein expression in this distinct cardiac tissue area is lost in *Rac1*^*SHF*^ hearts. We postulate that cardiomyocytes at the RV and interventricular junction must be highly polarized and oriented to align with the forming cardiac apex. The rounded, nonpolarized, and disorganized *Rac1*^*SHF*^ cardiomyocytes are likely unable to bridge the RV and interventricular junction to unify the 2 ventricles to form a cardiac apex, resulting in bifurcation of the muscular septum. In addition, a decrease in cell number due to increases in apoptosis in this area may also contribute to the development of bifid apex. It has been reported that genetic deletion of transcription factor *Ets1* also results in ventricular septal defects and bifid cardiac apex^[@b28]^; however, another group using the same *Ets1* knockout mouse did not observe a bifid cardiac apex.^[@b29]^ This makes the role of *Ets1* still unclear in the formation of a bifid cardiac apex. Recorded cases of bifid cardiac apex in humans are very rare and have usually been reported concomitantly with other congenital heart anomalies including atrial septal defects, ventricular septal defects, and defective RV development,^[@b30]--[@b31]^ which are very similar to the type of defects that were observed in *Rac1*^*SHF*^ hearts. Consequently, it is possible that the bifid cardiac apex and associated cardiac defects found in humans could be partially associated with abnormalities in *Rac1* signaling and defects in cardiomyocyte polarity during embryonic heart development.

It is well established that actin is the most abundant cytoskeleton protein and plays a critical role in controlling cell orientation, cell shape, and migration. Rac1 is an important regulator of actin polymerization, ruffle formation, lamellipodia extension, and migration in numerous cell types.^[@b7]^ Rac1 is known to activate the WAVE complex, which is recruited to the plasma membrane and regulates the actin cytoskeleton through the ARP2/3 complex. ARP2/3 associates with actin filaments to promote formation of new filaments from the sides of existing filaments, creating a dendritic network of branched actin filaments to extend lamellipodia and propel cells forward during migration.^[@b32]--[@b33]^ The combined defects in cell polarity, morphology, lamellipodia formation, and actin organization observed in SHF‐derived cells led to overall inhibition of cardiomyocyte migratory ability in *Rac1*^*SHF*^ embryos. Furthermore, Rac1 has been shown to promote cell survival by activation of the PI3K/Akt pathway.^[@b34]--[@b36]^ Decreased migration ability and an increased rate of apoptosis in SHF‐derived cells likely to contribute concomitantly to an overall deficiency in SHF contribution to the developing *Rac1*^*SHF*^ heart.

Numerous studies have found that Rac1 can regulate gene expression through different pathways. Interestingly, it has been shown that Rac1 can activate the canonical Wnt pathway by promoting nuclear accumulation of β‐catenin, the effector of the Wnt pathway.^[@b37]--[@b38]^ Ai et al showed that deletion of β‐catenin in the SHF led to abnormalities in development of the RV and interventricular septum,^[@b39]^ very similar to the defects observed in *Rac1*^*SHF*^ mice in the present study. Whether the defects were also due to loss of β‐catenin cell‐cell adhesion was not addressed in their study. Our data showed a loss of β‐catenin cell adhesions in the *Rac1*^*SHF*^ RV myocardium, supporting a defect in polarity and placing noncanonical Wnt signaling as the main driver of the cellular and morphological defects observed. Our data are supported by Abhul‐Ghani et al, who showed that noncanonical Wnt, which is highly active during cardiogenesis, antagonizes the canonical Wnt pathway.^[@b40]^ The contribution of canonical Wnt signaling cannot be ruled out in our study because it has been shown to play a role in specification and expansion of early SHF progenitors.^[@b41]^ Rac1 can also promote gene expression through NF‐κB and JNK pathways.^[@b42]--[@b43]^ Our data showed that *Rac1*^*SHF*^ hearts have decreased expression of *Gata4*,*Tbx5*,*Nkx2.5*, and *Hand2* transcription factors in the developing RV. Consequently, it is plausible that a Rac1 deficiency in the SHF will lead to decreased NF‐κB and/or JNK signaling and downregulation of key cardiac transcription factors during embryonic heart development. *Tbx20* acts in a dose‐sensitive manner as an essential regulator of outflow tract, cardiac valve, and RV development^[@b26]^; however, no significant downregulation of *Tbx20* expression was found in the *Rac1*^*SHF*^ hearts. A hierarchy of distinct cardiac transcription factor regulation exists in the developing heart.^[@b44]--[@b45]^ Our data suggest that Rac1 regulates a distinct network of cardiac transcription factors that do not include *Tbx20* in SHF derivatives. Future studies will be necessary to determine the exact downstream pathways that Rac1 regulates in the SHF to promote cardiac gene expression.

Tbx5 is essential in the SHF for atrial septation,^[@b46]^ although it is predominantly expressed in the LV during early heart development.^[@b47]--[@b48]^ In addition, Später et al recently challenged the view of Tbx5 as a classical first heart field marker^[@b49]^; they showed an overlap of expression pattern between the posterior end of the Tbx5‐positive first heart field domain and the Isl1‐positive SHF domain, suggesting a role for Tbx5 in the SHF. Our data are compatible with the studies on Tbx5 from Nadeau et al^[@b50]^ and Xie et al,^[@b46]^ who showed that Gata4 and Tbx5 cooperatively regulate atrial septum development and that haploinsufficiency of Tbx5 in the SHF results in atrial septal defects.

Although further investigations are required to analyze potential *RAC1* gene mutations in humans with bifid cardiac apex, the present study has shown that SHF *Rac1* is critical to septal and RV development and that deficiencies in SHF Rac1 can give rise to bifid cardiac apex along with the associated CHDs. Our data are the first to show Rac1 as an essential regulator of cardiomyocyte polarity during heart development and to provide a possible mechanism for how bifid cardiac apex arises. Establishment of cellular polarity is essential for the processes regulating cell morphology, lamellipodia formation, and cell migration in the developing embryo, and this seems to be especially critical in formation of a distinct cardiac apex during embryonic heart development.
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